Innoviva (INVA) Gross Margin (QoQ) (2011 - 2025)

Innoviva (INVA) Gross Margin (QoQ) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 -472.00
Jun 30, 2025 19.00
Sep 30, 2024 -337.00
Jun 30, 2024 -232,423.00
Sep 30, 2023 31,690.00
Jun 30, 2023 -23,099.00
Sep 30, 2022 -139.00
Jun 30, 2022 0.00
Dec 31, 2011 0.00
Sep 30, 2011 1,842.00